The company's stock was down 6.3% at 11:22 a.m. London time. Novo Nordisk, which manufactures the fiercely popular weight-loss drug Wegovy, previously forecast weight loss of 25% for patients who ...

equivalent to 3% of the national GDP in 2020. The analysis by Frontier Economics on behalf of pharma group Novo Nordisk calculates that £6.5 billion of that comes from direct costs to the NHS ...

The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic ...

For the current quarter, Novo Nordisk is expected to post earnings of $0.94 per share, indicating a change of +13.3% from the year-ago quarter. The Zacks Consensus Estimate has changed -2.2% over ...

THE WOODLANDS, Texas — A Houston-area pharmaceutical company has struck a billion-dollar deal with the seller of Ozempic for a potential drug also aiming to combat obesity. Lexicon ...